These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23764703)

  • 1. Endovascular cannulation with a microneedle for central retinal vein occlusion.
    Kadonosono K; Yamane S; Arakawa A; Inoue M; Yamakawa T; Uchio E; Yanagi Y; Amano S
    JAMA Ophthalmol; 2013 Jun; 131(6):783-6. PubMed ID: 23764703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
    Ehlers JP; Decroos FC; Fekrat S
    Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.
    McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
    Ophthalmology; 2010 May; 117(5):954-65. PubMed ID: 20163872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.
    Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H
    Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
    Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrity of foveal photoreceptor layer in central retinal vein occlusion.
    Ota M; Tsujikawa A; Kita M; Miyamoto K; Sakamoto A; Yamaike N; Kotera Y; Yoshimura N
    Retina; 2008; 28(10):1502-8. PubMed ID: 18997611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.
    Kumagai K; Furukawa M; Ogino N; Uemura A; Larson E
    Retina; 2007 Jan; 27(1):49-54. PubMed ID: 17218915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion.
    Yamamoto S; Saito W; Yagi F; Takeuchi S; Sato E; Mizunoya S
    Am J Ophthalmol; 2004 Dec; 138(6):907-14. PubMed ID: 15629280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
    Boyer D; Heier J; Brown DM; Clark WL; Vitti R; Berliner AJ; Groetzbach G; Zeitz O; Sandbrink R; Zhu X; Beckmann K; Haller JA
    Ophthalmology; 2012 May; 119(5):1024-32. PubMed ID: 22440275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion.
    Ota M; Tsujikawa A; Murakami T; Yamaike N; Sakamoto A; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Am J Ophthalmol; 2008 Feb; 145(2):273-280. PubMed ID: 18045566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
    Jain N; Stinnett SS; Jaffe GJ
    Ophthalmology; 2012 Jan; 119(1):132-7. PubMed ID: 21924503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab.
    Abegg M; Tappeiner C; Wolf-Schnurrbusch U; Barthelmes D; Wolf S; Fleischhauer J
    BMC Ophthalmol; 2008 Sep; 8():18. PubMed ID: 18823536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion.
    Ohashi H; Oh H; Nishiwaki H; Nonaka A; Takagi H
    Ophthalmology; 2004 Nov; 111(11):2050-6. PubMed ID: 15522371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.
    Park DH; Kim IT
    Retina; 2010 Jan; 30(1):117-24. PubMed ID: 19996831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.
    Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
    Ophthalmology; 2012 Jun; 119(6):1184-9. PubMed ID: 22424833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
    DeCroos FC; Shuler RK; Stinnett S; Fekrat S
    Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.